FDA's revitalization of medical device review and regulation.
作者信息
Kessler D A
机构信息
AAMI/NIH Cardiovascular Science and Technology Conference, Rockville, Maryland.
出版信息
Biomed Instrum Technol. 1994 May-Jun;28(3):220-6.
PMID:8061717
Abstract
摘要
相似文献
1
FDA's revitalization of medical device review and regulation.
Biomed Instrum Technol. 1994 May-Jun;28(3):220-6.
2
Conflict between FDA and medicine inevitable.
Diagn Imaging (San Franc). 1995 Oct;17(10):41-8, 87.
3
Strengthening the Evidence Base for Pediatric Medical Devices Using Real-World Data.
J Pediatr. 2019 Nov;214:209-211. doi: 10.1016/j.jpeds.2019.06.060. Epub 2019 Aug 1.
4
The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.
Clin Pharmacol Ther. 2016 Mar;99(3):265-8. doi: 10.1002/cpt.320. Epub 2016 Jan 12.
5
The Safe Medical Devices Act of 1990--FDA. Notice.
Fed Regist. 1991 Apr 5;56(66):14111-3.
6
Is FDA's medical device evaluation process overly complaisant to industry?
Healthspan. 1992 Jul-Aug;9(7):19-20.
7
Medical device safety: FDA's postmarket transformation initiative.
Food Drug Law J. 2007;62(3):593-6.
8
An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
IEEE Trans Neural Syst Rehabil Eng. 2007 Sep;15(3):421-4. doi: 10.1109/TNSRE.2007.903973.
9
Medical device epidemiology and surveillance: patient safety is the bottom line.
Expert Rev Med Devices. 2004 Sep;1(1):1-2. doi: 10.1586/17434440.1.1.1.
10
FDA's responsibility and involvement in the Y2K issue.
Biomed Instrum Technol. 1998 Nov-Dec;32(6):577-9.
Zotero 插件